Amyotrophic Lateral Sclerosis (ALS) 2027 supports New Jersey residents living with ALS and their families through clinical care and practical help at home to address care and daily mobility needs.
Assistive Technology Grants support investigators developing and adapting devices that help people with ALS communicate, move, breathe, and manage daily life to improve independence and quality of life.
This grant will fund research using data from expanded access to investigational drugs for ALS patients who are ineligible for clinical trials, aiming to improve prevention, diagnosis, or treatment of ALS.
The Hoffman ALS Clinical Trial Awards Program supports researchers conducting biomarker-driven early trials of ALS therapies and imaging tracers to advance treatment development and care.
ALS Finding a Cure funds research using AI and NLP to advance ALS diagnostics, biomarker discovery, disease modeling, and therapeutic innovation.
The FY27 Medical Homes Grants fund innovative research to advance the medical home model for autism care in New Jersey, supported by the NJ Governor's Council for Medical Research and Treatment of Autism.